Chapter 32 Pregnancy disorders
Introduction
Pregnancy is a special time in a woman’s life that should be enjoyed with good health. Due to a surge of hormones and rapid physical changes by the body, a number of distressing symptoms may arise, especially if the woman is unprepared. Many women conceive without planning a pregnancy, so it is not always possible to be prepared for a pregnancy. Hence it is vital that women optimise their health as soon as they make the decision to plan a pregnancy.
Complementary and alternative medicines (CAMs) are frequently used in pregnancy, more than prescription medicines, according to Australian research.1 These CAMs include massage (49%), vitamin and mineral supplements (30%) and yoga (18.4%) which are not likely to be harmful in pregnancy. The study highlighted more than three-quarters had used at least 1 complementary therapy 8 weeks prior to the study; one-third had used complementary medicine to alleviate a physical symptom such as headache, cough or cold with a 95% positive response to treatment compared with 6.8% of women on prescription medicine to treat a complaint.
Studies in the Netherlands found up to 36% of women were using herbs in pregnancy and up to 43% during breastfeeding.2 The most commonly used herbs in pregnancy include red raspberry leaf, ginger, chamomile3 and also echinacea and cranberry.2 Less commonly used supplements were fish oil, herbal teas, blue cohosh, acidophilus, ombeshi plums, homeopathic drops, peppermint and St John’s wort.
Symptoms of pregnancy
A number of problems can develop during pregnancy, including the following:4
Mind–body medicine
Sleep
A good nights sleep of up to 8 hours a night is essential in pregnancy and post-partum to help reduce fatigue, depression, mood disturbances and exhaustion. Recent evidence also suggests that a good nights sleep also contributes to shorter labour and an easier delivery.5 Women who slept for less than 4–5 hours per night were more likely to have caesarean deliveries and experience longer labour times compared with women who were well rested.5
Psychosocial and psychological factors
Many women experience anxiety during pregnancy and fear of pain, especially with a vaginal delivery. Studies suggest that personality factors such as general anxiety, neuroticism, low self-esteem and vulnerability, and dissatisfaction with their partners, violence in the relationship, lack of social support and unemployment will contribute and amplify pregnancy related anxiety.6, 7 Strategies such as increasing supports, meditation, counselling and cognitive behaviour therapy (CBT) should be aimed at reducing maternal anxiety and addressing issues with the partner. Even a telephone-based peer support line can make a significant difference in preventing postnatal depression among women at high risk.8
Duration between births
Women should be advised to avoid conceiving too quickly after giving birth to avoid subsequent birth complications. A large scale study of 89 000 women found shorter intervals between births (i.e. of less than 6 months between first and second pregnancy) was an independent risk factor for pre-term birth and neonatal death in the second pregnancy.9
Physical activity/exercise
It is clear that daily exercise benefits pregnant women both physically and emotionally but what is not certain is the level of intensity that is safe for pregnancy. A prospective study of 148 pregnant women examined whether vigorous exercise undertaken by recreational exercisers had any impact on infant birth weight and gestational age at birth.10 The researchers found there were no differences between the different exercise groups in pregnancy outcome, and duration or frequency of vigorous exercise was not associated with any adverse outcome for the infant, such as mean birth weight.
Regular exercise maintains and improves fitness during pregnancy, including aerobic exercise. However, larger and better trials are needed before confident recommendations can be made about the benefits and risks, such as pre-term birth, of more vigorous exercise in pregnancy.11
Environmental factors
Pollution
Pollution is a public health issue and can cause adverse health outcomes in pregnancy. A large Australian study of 28 000 births recorded during the study period found exposure to low levels of air pollution from vehicle exhausts, particularly in the 1st trimester, resulted in more premature births before 37 weeks gestation, the risk increasing by 15–26%.12 This association was strongest in winter and less in autumn compared with summer.
Smoking
Smoking should be completely avoided in pregnancy for its known adverse pregnancy outcomes that include intrauterine growth retardation, failure to thrive, low birth weight, premature death, fetal anomalies, and predisposition to asthma (maternal and child). Giving up smoking prior to pregnancy is preferred, although even ceasing early in the pregnancy (before 15 weeks gestation) can also be of benefit and reduce the risk of spontaneous pre-term birth and infants who are small for gestational age, according to a prospective cohort study.13
Smokers demonstrate lower levels of folate compared with non-smokers with similar dietary folate intake which may explain some of the negative pregnancy outcomes.14 Passive smoking is also harmful.
Recent evidence suggests smoking during pregnancy also increased the risk of children developing behavioural problems and hyperkinetic disorder by threefold compared with non-smokers.15
Alcohol
The Australian new-draft alcohol guidelines state that for pregnant women and women planning pregnancy no drinking is the safest option.16 A British study examining the effects of low–moderate prenatal alcohol exposure on pregnancy outcome found no convincing evidence of adverse effects.17 Similar findings have been found by a Western Australian group, however, alcohol intake at higher levels, particularly heavy and binge drinking patterns, was associated with increased risk of pre-term birth even when drinking was ceased before the 2nd trimester.18 Adverse effects of alcohol exposure on the fetus include fetal alcohol syndrome (1–3 % of live births), birth defects, neurodevelopmental disorders, miscarriage, still births, pre-term births and low birth weight.
Fetal alcohol exposure can be minimised through abstaining or reducing alcohol consumption or increasing effective contraception in females who engage in risk drinking.19
Animal studies suggest dietary zinc supplementation may play a role in preventing fetal alcohol syndrome due to prenatal ethanol exposure, although more studies are required.20
Maternal obesity
It is natural for a woman to gain on average up to 18kg during pregnancy without risking complications, although the recommended weight range is from 11.5 to 16kg.21 The optimal birth weight for the infant is 3500–4500g. Women gaining weight at the lower end of the recommended range had a higher chance of low birth weight newborns weighing less than 3500g.
A study of 100 pregnant women were randomised to a program of dietary and lifestyle counselling that helped reduce excessive weight gain during pregnancy compared with the routine prenatal care group, who also had significantly more caesarean deliveries by 58.6% due to failure to progress (compared with lifestyle counselling group 25.0%, P = .02).22
Obesity is an independent risk factor for negative, adverse pregnancy outcome. It contributes to infertility, miscarriage, hypertension, increased deep vein thrombosis and pulmonary embolisms, pre-eclampsia, gestational diabetes, prematurity, congenital anomalies, fetal distress, still birth, longer labour, caesarean delivery, subsequent post-operative complications, and cardiovascular risk factors.23–26
A large scale cohort study of 54 000 pregnant women found the risk of fetal death (stillbirth) for obese women (Body Mass Index [BMI] >30) doubled by week 28 of gestation and quadrupled by week 40 compared to normal weight women.27 They found that obesity was associated with placental dysfunction.
Nutritional influences
Diet
Mediterranean diet
Of interest, the Mediterranean diet characterised by high intakes of fruit, vegetables, olive oil, fish, legumes, and cereals and low intakes of potatoes and sweets, is associated with reduced risk of Spina bifida in offspring compared with maternal intake not on Mediterranean diet.28 The Mediterranean diet also correlated with higher levels of serum and RBC folate, serum vitamin B12 and lower plasma homocysteine.
Western diet
Maternal consumption of the Western diet (e.g. high in meat, pizza, legumes, and potatoes, and low in fruits) increases the risk of offspring with a cleft lip and/or cleft palate by approximately twofold.29 The authors postulated low folate levels in the Western diet may account for this association and, therefore, recommend dietary and lifestyle profiles should be included in preconception screening programs.
Fish and heavy metal exposure in pregnancy
Fish is an important part of dietary intake. It contains a number of essential nutrients such as eicosopentaenoic acid (EPA) and docosohexaenoic acid (DHA), important for development of the fetal brain and retina, and is rich in iodine, iron, choline, selenium, and trace elements important for pregnancy and fetal growth. Also meta-analysis of the literature indicates maternal diet high in fish may reduce the risk of inflammatory conditions such as rheumatoid arthritis, atopy and asthma in the newborn, although more evidence is required.30, 31
Health benefits of fish may counterbalance any adverse effects of mercury exposure on the developing nervous system.32 All fish contains some mercury in their flesh, mostly in the form of organic methyl mercury (MeHg), a known neurotoxin which can cause developmental delay, neurological problems and damage to the developing central nervous system (CNS). The quantity of MeHg present in fish varies depending on the dietary habits and age of the fish, and is particularly concentrated in the larger predatory fish at the top of the food chain.
Foods Standards Australia New Zealand (FSANZ) has useful advice on mercury in fish.33 FSANZ found that most fish is safe for all population groups to eat 2–3 serves per week and recommends that pregnant women, women planning pregnancy and young children continue to consume a variety of fish as part of a healthy diet, but limit their consumption of the larger predatory fish such as shark, marlin, broadbill and swordfish (containing highest levels of MeHg) to no more than 1 serve per fortnight with no other fish to be consumed during that fortnight. For orange roughy (also sold as sea perch) and catfish, the FSANZ advice is to consume no more than 1 serve per week, with no other fish being consumed during that week.33
Nutritional risk factors in pregnancy
The increased needs during pregnancy can vary from 12% for dietary fibre, 14% for vitamin A, 46% for vitamin B6, 50% for folate, 37% for zinc, 50% for iron, 46% for iodine, 30% for protein and 25% for essential fatty acids.34, 35
Teenage pregnancy requires special needs as a mother’s body is still growing in many instances. The ideal weight gain for teenage pregnancy is 10kg; lower weight gain can lead to lower birth weight which can be associated with greater risk of developing type 2 diabetes and hypertension later in life, as well as a weight problem.27
Routine supplementation with iron, vitamin A, C and E are not recommended in pregnancy. 36
Nutritional supplements
Fish oil for pregnancy and breastfeeding
Fish oils play an important role in pregnancy and in the development of the fetus and newborn. Pregnant women should be encouraged to eat at least 3 deep sea fish a week although there are real concerns with heavy metal toxicity in the larger predator fish (see section titled ‘Fish and heavy metals’).37 A number of studies demonstrate fish oils can significantly reduce the risk of atopy, asthma (see Chapter 5 for asthma information) and other immune-mediated diseases by positively modulating inflammation and prostaglandin effects on the newborn child. In addition, the benefits of fish oils are carried through to breastfed babies. In bottle-fed babies, the benefits are through formulas enriched with fish oils.38–42
For instance, a population-based study of 533 pregnant women from 30 weeks gestation to birth were randomly assigned to receive 4 x 1g gelatin capsules/day of fish oil (2.7g n-3 PUFAs) or 4 x 1g similar-looking capsules/day with olive oil, or no oil capsules.43 Over a 16-year follow-up of offspring, the risk of asthma was reduced by 63% and of allergic asthma by 87% in those pregnancies treated with fish oil compared with the olive oil group. This study supports a potential prophylactic role of fish oils late in pregnancy, reducing risk of asthma in the newborn.43
Women consuming fish oil supplements compared with olive oil capsules were also less likely to experience pre-term delivery and more likely to reach full term without any complications.44 The high intake of fish oils might prolong pregnancy by shifting the balance of production of prostaglandins in parturition.
Fish oils play an important role in the development of the nervous system and augments cognitive function, IQ, vision and behaviour in offspring to mothers supplemented with fish oils during pregnancy and breastfeeding.45–60
However, a double-blind study randomised pregnant mothers to take 10ml of either cod-liver oil or corn oil from 18 weeks gestation until 3 months after delivery.61 At 7 years of age, children were assessed and the researchers found higher maternal plasma phospholipid concentrations of alpha-linolenic acid (18:3n-3) and docosahexaenoic acid during pregnancy were correlated with enhanced cognitive function, such as sequential processing, but no significant effect was observed on global IQs or on BMI in the children.
Multi-nutrients and pregnancy
Micronutrients such as vitamins and minerals are necessary for the growing demands experienced by the pregnant mother and for the normal functioning, growth and development of the fetus. A Cochrane review of 9 trials including 15 378 women demonstrated multi-nutrient supplementation reduced the number of low birth weight and small-for-gestational-age babies and maternal anaemia, but close analyses of the data revealed no added benefit compared with iron/folic acid supplementation alone.62 Further research is required to confirm the benefits of taking multi-nutrients during pregnancy.
A systematic review and meta-analysis of the use of prenatal supplementation with multivitamins found that they decreased the risk for paediatric brain tumour, neuroblastoma and leukaemia.63
Vitamin A deficiency
Vitamin A deficiency is common in developing countries such as Indonesia and Nepal due to poor nutritional intake where daily or weekly supplementation may be necessary as deficiency of vitamin A causes night-blindness, anaemia and other problems.64 However, in women with adequate nutritional intake, vitamin A supplementation can cause toxicity, especially doses >10 000IU/day, and should be avoided. Toxic levels can cause miscarriage and birth defects. Note: beta-carotene intake is very safe.
Vitamin C deficiency
It is not clear if taking vitamin C supplementation in pregnancy is safe, because a Cochrane review found in a trial that vitamin C supplementation was linked with a moderate risk of pre-term birth, although more studies are required to confirm this adverse effect.65 Vitamin C deficiency is linked with complications in pregnancy such as pre-eclampsia, anaemia and intrauterine growth retardation, and so women should be encouraged to eat foods rich in vitamin C such as fruit.
Vitamin D deficiency
Severe vitamin D deficiency can cause maternal osteomalacia and lead to significant morbidity in the mother and fetus. The prevalence of vitamin D deficiency in pregnant women is high and this can have serious health ramifications in the mother and child.66, 67 Pregnant women who are deficient in vitamin D can lead to reduced weight gain and pelvic deformities that prevent normal delivery. For the fetus, vitamin D deficiency is linked with poor fetal growth, low birth weight, neonatal hypocalcemia with and without convulsions, neonatal rickets, defective tooth enamel, and pre-disposition to childhood rickets, particularly in breastfed, dark skinned children.68, 69, 70 Deficiency is common in populations residing in geographically prone areas such as southern Australia (e.g. Melbourne) and in some high-risk communities such as migrants, women wearing veiled clothing, and people who spend more time indoors.71 Ninety percent of the body’s vitamin D is produced by the skin from sunlight (ultraviolet B light) exposure of non-covered skin without sunscreen, with only 10% coming from dietary sources. It is essential to restore vitamin D deficiency in mothers by advising safe sun exposure which is dependent on geographical areas and pigmentation of the skin (the darker the skin the more sun that is required), and supplement with cholecalciferol if needed, but this needs to be done cautiously to avoid vitamin D toxicity. Excessive vitamin D may cause hypercalcemia and fetal harm. Doses within RDI are safe. According to a Cochrane review of the literature, there is not enough evidence to date to evaluate the effects of vitamin D supplementation in pregnancy.72 Vitamin D is excreted in milk in limited amounts, and with excessive use can cause toxicity in infants. If pharmacological supplementation is required, it is essential to monitor calcium levels in the infant and get maternal vitamin D checked regularly.
Folate deficiency
Folate is one of the most important nutrients for healthy fetal development. Pregnant women and the growing embryo require higher levels of folate for cell replication and growth. Rapidly dividing cells in the embryo fail to produce healthy DNA if folate levels are low. The recommended daily intake for folate is increased significantly by 50% in pregnancy. It is recommended that every woman planning a pregnancy should take 500mcg folate a few months prior to pregnancy and in the 1st trimester although recent studies indicate that folate supplementation in the 2nd trimester may help prevent pre-eclampsia.73 Low folate levels are associated with increased risk of spontaneous abortion, anaemia, low birth weight and congenital malformations such as neural tube defects (NTD), oral clefts and cleft palate, and cardiovascular and urinary tract malformations.74, 75 Overall, nutritional deficiency in the pregnant woman (not just folate deficiency) can increase the risk of orofacial cleft. Increasing intakes of vegetables, protein, fibre, fruit, ascorbic acid, iron, vitamin Bs and magnesium also reduce the risk of orofacial cleft.76, 77
Folate is essential for fetal brain and spinal cord development. A Cochrane review evaluated 4 trials of folate supplementation involving 6425 women. Peri-conceptional folate supplementation significantly reduced the incidence of NTD (relative risk 0.28, 95% confidence interval 0.13 to 0.58) without significant harmful effects such as miscarriage, ectopic pregnancy or stillbirth. The authors also found multivitamins were not associated with any additional beneficial preventative effects of NTDs even when given with folate.78
Medications interfering with folate
Maternal exposure to folate antagonist medication such as sulfamethoxazole-trimethoprim and anti-epileptic medication such as phenobarbital and sodium valproate may contribute to adverse pregnancy outcomes by affecting placental function, although more studies are required to confirm this finding and one needs to weigh the benefit to any potential risk.79, 80 It is important to avoid any medication and herbal medicines that may harm the fetus in pregnancy unless there is a clear risk to the mother.
Anti-epileptic medication and folate
Pregnant women who require anti-epileptic medication, many of which antagonise folate action, are at increased risk of fetal abnormalities and birth defects such as NTDs.81 Epileptic women in reproductive years should be advised to take folate peri-conceptually if on anti-epileptic medication that interferes with folate, although it is not clear what this dosage should be.
Women of child-bearing age prescribed, for example, sodium valproate should be warned about the potential risks of the drug, including teratogenesis, and should be strongly advised to ensure adequate contraception whilst taking this drug.82, 83
Minerals
Iron deficiency
The recommended daily intake for iron is increased significantly, by 50%, in pregnancy. Iron deficiency is linked with infertility, anaemia, increased risk of infection, fatigue, and behavioural and cognitive development problems.84, 85, 86 It is possible that fetal oxygenation is compromised with iron deficiency.85 While the benefits are clear for iron supplementation, if the mother demonstrates serum iron deficiency with or without anaemia, at this stage, there is not enough evidence to recommend routine iron supplementation in all pregnant women.87
Zinc deficiency
Zinc is an essential trace element and plays an important role in normal growth and development, protein synthesis and cellular integrity. Zinc deficiency can adversely effect pregnancy outcome, such as pre-term birth, intrauterine growth retardation, poor fetal bone growth and prolong labour.88, 89 Zinc deficiency is common in low socioeconomic groups with poor nutritional intake and in third world countries. A trial of zinc supplements in HIV pregnant women improved infant mortality, birth weight and duration of pregnancy.90 Its benefit was related to improving immune status.
Foods rich in zinc are found in pecans, wholegrains, lima beans, almonds, walnuts, hazelnuts, sardines and chicken. A Cochrane review of 17 randomised controlled trials (RCTs) involving over 9000 women and their babies demonstrated zinc supplementation resulted in a significant reduction in pre-term birth by 14%, reduced need for caesarean section and in 1 trial demonstrated reduced need for induction of labour, but did not reduce the risk of babies with low birth weight.91 In a study held in Bangladesh, babies of women who took 30mg/day of elemental zinc during pregnancy were less likely to develop acute diarrhoea by 16%, dysentery by 64% and impetigo by 47%, compared with mothers on placebo.92
Iodine deficiency
Iodine is an essential trace element for the production of thyroid hormones T3 and T4. Studies indicate mild deficiency of iodine is common in pregnant women.93 Sources of iodine include ocean fish, spinach, seaweed (such as kelp), garlic, watercress, citrus fruit, cereals, nuts (cashews), egg yolk and iodised salt. Researchers suggest pregnant women need to increase their intake of iodine and, if deficient, should consider supplementation from 100–200mcg/day.
A high frequency of iodine deficiency is known to occur in Australia, with almost 20% of pregnant women having a moderate to severe iodine deficiency. Mild deficiency occurred in almost 30% of women.94
Maternal iodine deficiency is known to cause neonatal cretinism. A suboptimal iodine intake by pregnant females without overt deficiency may compromise fetal development, even in the absence of cretinism, leading to developmental delays in the infant.95
It is possible to prevent cretinism with iodine supplementation pre-conception, and also if supplementation is given before the end of the 2nd trimester.96
Medical conditions associated with pregnancy or a complication of pregnancy
Gestational diabetes mellitus (GDM)
Between 1 to 14% of women develop GDM during pregnancy. Dietary advice is essential to help reduce the incidence of diabetes in pregnancy and subsequently in life. GDM can cause significant health problems, such as a very large baby, and increase the risk of negative and adverse pregnancy outcomes, such as an increased risk of induced birth and caesarean section, prematurity and increased infant morbidity and mortality. GDM is also associated with an increased risk of diabetes for mother and child later in life.
Depression as a risk factor for GDM
Among low-income pregnant women, those with diabetes (pre-existing of gestational) were twice as likely to suffer peri-natal depression and more likely to have post-partum depression after adjustment for other confounding factors, according to a retrospective cohort study.97
Lifestyle and GDM
Lifestyle risk factors play a role in the development of diabetes in any person and these include stress management, sunshine for vitamin D, dietary factors, exercise and sleep strategies. (See Chapter 13 for diabetes and Chapter 22 for sleep.)
Exercise and GDM
An analysis of 21 765 women as part of the Nurses Health study II found that women who perform regular exercise, especially brisk walking 30 minutes daily, before pregnancy have a significantly reduced risk of developing GDM, by up to 34%, when compared with women who did the least amount of exercise.98
Low GI diet and GDM
A low GI diet can effectively halve the need to use insulin compared with a high GI diet, according to a recent randomised study.99
A Cochrane review identified 3 trials including 107 women.100 Two trials assessed low versus high GI diets for pregnant women. Women on low GI diets, had less large-for-gestational-age infants and lower maternal fasting glucose levels. The other trial assessed high fibre versus control diet but the trial did not report on the outcomes. The reviewers concluded based on these findings that whilst ‘a low glycaemic index diet was seen to be beneficial for some outcomes for both mother and child, results from the review were inconclusive’.100
Weight gain and GDM
Women of reproductive age should be encouraged to maintain a normal healthy weight as weight gain and maternal obesity is associated with increased risk for diabetes, adverse pregnancy and neonatal outcome.101 See the maternal obesity section earlier in this chapter.
Pre-eclampsia (PE)
Exploring diet and lifestyle are essential to lower the risk of developing PE, particularly increasing nutrient rich foods for antioxidants, vitamin E, calcium and magnesium as deficiency of these nutrients can predispose to PE. This is commonly seen in under-nourished, low socio-economic communities. A diet high in sugar and fat, cigarette smoking and low physical activity are known risk factors for PE. Stress is a contributor to PE-like hypertension. It is likely other lifestyle risk factors may also play a role in PE and strategies such as stress management, dietary changes (increasing vegetables, high fish intake), exercise and sleep restoration should assist in the management of PE (see Chapter 19 on hypertension). Calcium and magnesium appear to be particularly effective and may play an important role as therapeutic agents for PE. PE can cause serious morbidity and can lead to death in pregnant women, who should be monitored closely, including for onset and progression of chronic kidney disease.102
Stress and PE
Work stress is a significant predictor and risk factor for developing PE.103 In a trial on pregnant normotensive women, heart rate increased and mean arterial blood pressure rose by more than 2.9mmHg, and in some up to 10mmHg on work days.104 Higher blood pressures occurred in women experiencing greater job stress.
Fibre and PE
High dietary fibre plays an important role in the prevention of PE. A study of over 1500 pregnant women found that women consuming more than 21.2g/day of fibre were associated with reduced risk of PE by up to 70% and mean concentrations of triglycerides was higher and high density lipoprotein (HDL) cholesterol was lower compared with women consuming less than 11.9g of fibre daily.105
Salt and PE
Whilst a low salt diet is recommended for the prevention of hypertension, there is currently insufficient evidence to advise reduction of dietary salt during pregnancy for the prevention of PE and its complications.106
Antioxidants and PE
Findings from a Cochrane review could not recommend the use of antioxidants for the prevention of PE107 although another Cochrane review found women taking vitamin supplements ‘may be less likely to develop pre-eclampsia and more likely to have a multiple pregnancy’.108
Vitamins C and E and PE
Inadequate dietary intake of vitamin E during pregnancy is associated with PE and low birth weight. A Cochrane review found in trials that pregnant women supplemented with vitamin E in combination with other supplements compared with placebo were at reduced risk of developing clinical PE, however, the data was too few to recommend supplementation in pregnancy at this stage.109
One double-blind RCT of 283 women at risk of PE (previous history of PE or placental blood flow abnormalities) were assigned to 1000mg/day of vitamin C and 400IU/day of vitamin E or placebo at 16-22 weeks gestation.110 Vitamin supplementation correlated with a significant 21% reduction in plasma markers reflecting endothelial and placental function. Plasma ascorbic acid increased 32% on average, and the α-tocopherol level increased by 54%. PE developed in 17% of placebo recipients but in only 8% of women given vitamins. Furthermore, small-for-gestational-age infants were less frequent, although less significant in the vitamin-supplemented group. Subsequent research demonstrated similar findings.111, 112
Another study found 1000mg of vitamin C or 400IU of vitamin E did not reduce the risk of PE compared with placebo, however, the synthetic form of vitamin E was used in this study.113 Women should be encouraged to eat foods high in vitamin E found in vegetable oils, nuts, cereals and some leafy green vegetables.
However, a recent study warns against peri-conception use of vitamin E supplements with high dietary vitamin E intake above 14.9mg/day as it increased the risk of congenital heart defects (CHDs) in offspring by nine fold.114
Folate and PE
A prospective cohort study of 2951 women at 12–20 weeks gestation found supplementation with multivitamins containing folic acid in the 2nd trimester reduced the risk of developing PE.73
Mineral supplementation for PE
Calcium and PE
In a review of the literature of RCTs found calcium supplementation to play an important role in the prevention of PE and pre-term delivery more than any other supplement.115
A randomised placebo-controlled study of 524 healthy first-time pregnant women whose mean dietary calcium was less than RDI, found 2g of elemental calcium supplementation daily during pregnancy was associated with a significant reduced risk of PE by 69% and pre-term delivery by 49% compared with placebo.116, 117
Furthermore, a Cochrane review of the literature of 12 good quality trials supports the findings that calcium may play an important role in the prevention of PE, the authors concluding that calcium supplementation could ‘almost halve the risk of PE, and reduce the rare occurrence of the composite outcome death or serious morbidity’.118
Magnesium and PE
According to a Cochrane review magnesium supplementation during pregnancy may be able to reduce PE and fetal growth retardation.119 In a large scale international trial from 33 different countries 10 141 pregnant women were randomised to magnesium sulfate or placebo. The trial was cut short due to the positive conclusive findings demonstrating magnesium sulfate led to a significant 58% reduction of PE and 45% reduction in maternal death compared with placebo.120
Herbs for PE
Garlic and PE
Meta-analyses have demonstrated that garlic is a valid therapeutic treatment for hypertension, but its role in PE is not so clear. (See Chapter 19 for hypertension information.) A Cochrane review identified 1 study of 100 pregnant women that showed dried garlic capsules did not prevent PE compared with placebo and demonstrated no significant differences in side-effects except women on garlic reported odour.121
Hyperemesis gravidarum (HG)
Nausea and vomiting
Many trials have compared the use of vitamin B6 and ginger with anti-emetic medication. A Cochrane review of the literature found anti-emetic medication to reduce the frequency of nausea but there is little research that explores adverse fetal outcome from this medication and it can cause side-effects such as drowsiness in the mother. The reviewers found evidence for ginger, acupressure (of pericardium P6) and vitamin B6 in reducing severity of nausea and vomiting.122
Vitamin B6 and nausea
Vitamin B6 needs to be used with caution as high doses (more than 50mgs/day) and prolonged use have been associated with neurotoxicity such as peripheral neuropathy (e.g. tingling, burning and numbness of limbs), and should be stopped immediately should these symptoms develop.123, 124 Vitamin B6 should be used cautiously for therapeutic purposes and not used routinely, although a trial did suggest it may protect against tooth decay in pregnant women.125, 126
Ginger (zingiber officinale) and nausea
Ginger is a popular remedy used by pregnant women for the treatment of nausea in pregnancy. A Cochrane review of 6 RCTs involving 675 pregnant women assessed the evidence for efficacy and safety of ginger therapy for nausea and vomiting in early pregnancy.127 The authors concluded that ginger may be an effective treatment choice for nausea and vomiting associated with early pregnancy but further studies with larger numbers of women are required to confirm the promising preliminary data for the safety of this therapy. Four of the 6 RCTs showed superiority of ginger over placebo and 2 of them showed equivalence to vitamin B6 in relieving the severity and episodes of nausea and vomiting.128
Acupuncture, acupressure and nausea
A Cochrane review identified 26 trials of 3347 participants suffering nausea and vomiting and found significant reduction in the risk of nausea and need for anti-emetic medication with acupuncture point stimulation (pericardium 6) compared with sham acupuncture.129 There were minimal side-effects with this method. This treatment should be considered for pregnant women suffering severe nausea.
Cramps
Calcium and magnesium can provide effective treatment for pregnancy-induced leg cramps.131, 132, 133
Ectopic pregnancy
Ectopic pregnancy occurs in 1–2% of pregnancies and is a leading cause of pregnancy-related deaths in the 1st trimester. Whilst traditional Chinese herbal medicines are used in China to treat ectopic pregnancy, most of the trials are of poor quality.134 Surgery is highly recommended for the treatment of any ectopic pregnancy, and to exclude any predisposing factors to ectopic pregnancy, such as fallopian tube disorders.
Miscarriage
Lifestyle and miscarriage
A large UK population case-control study identified risk factors for 1st trimester miscarriage and found lifestyle factors and stress play an important role in increasing the risk of miscarriage.135 The findings of this case-control population-based study are summarised in Table 32.1.18,135
Table 32.1 Lifestyle and behavioural risk and protective factors for miscarriage
Increase risk of miscarriage | Protective factors for miscarriage | No association with miscarriage |
---|---|---|
(Source: Maconochie N, Doyle P, Prior S, Simmons R. Risk factors for first trimester miscarriage — results from a UK-population-based case-control study. BJOG 2007;114(2))
Caffeine and miscarriage
Furthermore, a recent study suggests caffeine consumption of at least 2 cups daily (200mg or more) increases the risk of miscarriage by up to 40% compared with women with no intake of caffeine.136
Nutritional factors and miscarriage
A Cochrane review of the literature found research to date indicates that pregnant women taking a daily multivitamin supplementation prior to or early in pregnancy does not reduce the risk of miscarriage or stillbirth.137 It is likely that supplements used did not contain enough of the nutrients that can be protective. The quality of the nutrients is also important. The amount of nutrients and the type of nutrient, especially whether they were synthetic or natural, may have been an important factor in this study, which could explain this unexpected result.
Despite these findings, numerous studies have demonstrated the association between increased homocysteine and spontaneous miscarriage.138, 139 Folic acid and vitamin B6 and B12 take part in the metabolism of homocysteine.
Coeliac disease is associated with damaged intestinal mucosa leading to a malnourished state caused by the malabsorption of macro and micronutrients. Miscarriages are more frequently observed in those with coeliac disease.140 Therefore coeliac disease must be considered in the pre-conceptional screening and treatment of patients with reproductive disorders.
Iodine deficiency is a risk factor for growth and development of up to 800 million people living in iodine deficient environments throughout the world. The effects on growth and development, called the Iodine Deficiency Disorders, includes miscarriages.94, 95, 96 Poor diet or diets that are vitamin deficient such as folate have been associated with an increased risk of women losing their baby early in pregnancy.141
Congenital heart defect (CHD) in newborn
Saturated fats, riboflavin and nicotinamide and newborn CHD
Fatty acids play an important role in embryonic development, and B-vitamins riboflavin and nicotinamide play a role as co-enzymes in lipid metabolism. Vitamin B deficiency is linked with increased incidence of CHD.144 A study demonstrated that maternal diets low in dietary riboflavin (<1.20mg/d) and nicotinamide (<13.5mg/d) increased the risk of a child with CHDs by twofold, especially in mothers who did not take multivitamins, and particularly those on high saturated fatty diets.145 These findings were independent of dietary folate intake.
Pre-term birth, low birth weight, fetal failure to thrive
Stress and pre-term birth (PTB)
Epidemiological evidence suggests that maternal psychosocial stress, strenuous physical activity and fasting are independent risk factors for PTB and low birth weight.146
Depression, anxiety, stress and PTB
Depression and anxiety are risk factors for pre-term labour. Screening of pregnant women for depression may be useful as antenatal depression is significantly associated with almost twice the risk of pre-term delivery (before 37 weeks) compared with non-depressed women, according to a cohort study of 791 women assessed at 10 weeks gestation and followed up during pregnancy.147 Severe depression increased the risk by up to 2.2 times compared with women not suffering antenatal depression. The authors concluded that their findings show that pregnant women with depressive symptoms are a risk factor for PTB and exacerbated by stressful events, low educational level, and a history of fertility and obesity. It is likely excess cortisol produced in response to stress may play a role, although other factors may also contribute.
A study of 634 pregnant women revealed that depression was positively associated with underweight women (pre-pregnancy BMI below 19) and together with anxiety correlated with a higher incidence of pre-term delivery.148 Anxiety also correlated with vaginal bleeding. These findings indicate that depression and anxiety are associated with spontaneous pre-term labour.
Yoga reduces risk of PTB, PE, intrauterine growth retardation
A study demonstrated yoga consisting of gentle, daily physical postures, meditation and breathing improves pregnancy outcome, significantly reduces risk of PE, intrauterine growth retardation, pre-term labour and low birth weight newborns.149 No significant adverse events were reported in the yoga group. Yoga helps with relaxation, postural and stretching exercise so may have benefits in other areas of pregnancy, such as anxiety, headaches and back pain.
Exercise reduces risk of PTB
Vigorous exercise in pregnancy, such as swimming, cycling and aerobics, reduces risk of pre-term birth by 20% when engaged in the 1st trimester and by 50% in the 2nd trimester.150
Poor dental hygiene and PTB
A meta-analysis of RCTs concluded periodontal disease treatment with scaling and/or root planning during pregnancy may significantly reduce PTB or low birth weight infant incidence, but not spontaneous abortion or stillbirth.151
Maternal periodontitis and PTB
It is known that a number of diseases including cardiovascular diseases, respiratory diseases, diabetes mellitus and osteoporosis are linked to periodontitis. A number of studies have found that maternal periodontitis can lead to adverse pregnancy outcomes including pre-term, low birth weight or small-for-gestational-age babies.152, 153
Smoking and PTB
Numerous studies have investigated the influence of smoking on the outcome of pregnancy. A large US study found that small fetal size at 10–19 weeks is associated with tobacco use in pregnancy, early pre-term births and low birth weight plus poor fetal growth.154 This finding is supported by another study.155
An Australian study concluded that smoking by indigenous and non-indigenous mothers led to growth restriction in full-term births.156
Mothers who are able to quit smoking early in pregnancy reduced the risk of having a pre-term or low birth weight baby to nearly that of mothers who did not smoke.157
A systematic review and meta-analysis investigated the role of environmental tobacco smoke and has shown that this too can lead to fetal failure to thrive.158
There is a clear dose-related impact of smoking on risk of spontaneous pre-term labour and should be avoided in pregnancy.159 The highest risk occurred in women who smoked more than 10 cigarettes daily.
Diet and PTB
Fish reduces risk of PTB
A study of over 8700 pregnant women demonstrated that eating as little as 15g/day of fish significantly reduced the risk of pre-term delivery or having a low birth weight baby compared with women not eating any fish.160 Pregnant women who did not eat fish increased their risk of pre-term delivery or having a low birth weight baby by up to 3.5 times compared with fish eaters.
In another study researchers found a significant reduction of 90% of pre-term delivery among healthy women on fruit, vegetables, wholegrains and low cholesterol diet substituted with fatty fish, vegetable oils, nuts and nut butter in place of meat, butter, cream and fatty dairy foods.161 This has enormous health implications and reinforces the important role of women of child-bearing age to be on a healthy low cholesterol diet.
Caffeine effects and PTB
Studies consistently demonstrate the adverse effects of maternal caffeine consumption on fetal development.162–165 A large prospective observational study of over 2600 low-risk pregnant women showed maternal consumption of caffeine from 100mg/day to over 300mg/day (1–3 cups/day) at any stage throughout the pregnancy was associated with a significant risk of fetal growth restriction.166 An intake of 200mg/day of caffeine was associated with a significant reduction of birth weight by 60–70g, and consumption of caffeine >100mg/day with each trimester led to drops in birth weight by 34–59g in the 1st trimester, 24–74g in the 2nd and 66–89g in the 3rd trimester. Caffeine is rapidly absorbed and crosses the placenta freely. Cytochrome P450 1A2, the principal enzyme involved in caffeine metabolism, is absent in the placenta and the fetus.
A recent study confirms these findings and demonstrated that the equivalent of only 1 dose of caffeine (just 2 cups of coffee) ingested during pregnancy may be enough to affect fetal heart development.167 The authors strongly advise pregnant women should not consume coffee.
Another study found that coffee consumption during pregnancy was associated with miscarriage, in particular if more than 3 cups of coffee were consumed per day.168
Fish oil supplements protect against PTB
Long chain polyunsaturated fatty acids are essential for infant growth and development. Maternal intake of 500mg DHA-rich tuna fish oil supplements taken daily during lactation improved cognitive development and reduced risk of developmental delay in pre-term babies when assessed at 18 months.169 The main side-effect was a ‘fishy burp taste’.
Magnesium protective for PTB
Magnesium is a promising nutrient not only for PE treatment but also in the prevention of pre-term labour and birth. An analysis of trials involving over 2600 pregnant women found oral magnesium treatment in early pregnancy was associated with reduced risk of pre-term birth, a lower frequency of low birth weight and less small-for-gestational age infants compared with placebo.170 Furthermore, the women treated with magnesium required less hospitalisation during pregnancy and less risk of antepartum haemorrhage compared with placebo treated women. However, the Cochrane review noted the poor quality trials are likely to have resulted in a biasness favouring magnesium supplementation and concluded at this stage that there is ‘not enough high quality evidence to show that dietary magnesium supplementation during pregnancy is beneficial’.170
A recent Cochrane review of 5 trials involving 6145 babies demonstrated giving intravenous magnesium sulfate to women at risk of pre-term birth significantly reduced the risk of cerebral palsy and the overall mortality of the infant.171 Side-effects included nausea, vomiting, headaches and palpitations. Epidemiological and scientific studies suggest that magnesium sulfate before birth may be neuroprotective for the fetus.
Placental disruption
Multivitamins and folate
A large population-based study of 280 127 deliveries recorded over a 5-year period demonstrated that women who took any supplement during pregnancy had a 26% reduced risk of developing placental disruption, folate supplement reduced the risk by 19% and a multivitamin supplement was associated with a 28% reduction compared with no supplementation.172 Combining folate with multivitamins reduced the risk of placental abruption by a further 32%.
Failure to thrive
Poor nutrition and failure to thrive
Birth weight is a key determinant of natal mortality, morbidity, subsequent growth and development, as well as early onset of adulthood diseases.173
Poor nutrition is especially common in developing countries where fetal failure to thrive is a common problem. 64, 65, 66, 174 The role of diet and specific nutrients in avoiding failure to thrive are discussed earlier in this chapter.
Premature rupture of membranes (PROM)
Occupational fatigue and PROM
A large-scale study of 2929 pregnant women at 22 to 24 weeks gestation were enrolled in a multi-centre (10 sites) as part of the Pre-term Prediction Study, which identified a high volume of working hours and occupational fatigue as significant risk factors for PROM. This was particularly evident in nulliparous compared with multiparous women.175
Frequency of meals and PROM
Poor nutritional status is a risk factor to developing PROM. Pregnant women who eat only once daily had a slightly increased risk of having a pre-term birth and a significant risk of developing PROM compared with women who ate 3 times daily.176
Vitamin C and E and PROM
Vitamin C is required for the synthesis of collagen and plays an important role in the maintenance of chorioamniotic membranes. Low dietary vitamin C intake before conception and during 2nd trimester is a risk factor for PROM and pre-term delivery.177
A randomised double-blind trial of 109 pregnant women found daily supplementation with 100mg of vitamin C reduced the risk of PROM up to 20 weeks gestation compared with placebo.178 Pregnant women should be encouraged to ingest a diet high in vitamin C rich foods such as red sweet peppers, kale, parsley, fruit, and tomatoes. Where there is a strong history of recurring PROM, supplementation with vitamin C may be warranted.
Vitamin E is a lipid-soluble antioxidant that inhibits membrane-damaging effects of reactive oxygen species-induced lipid peroxidation. It is hypothesised that dietary vitamins C and E in low doses may prevent damage by reactive oxygen species that can impair fetal membrane integrity and reduce mid-gestation levels of vitamin C associated with PROM.179
Genital tract infections
Pre-term labour can be caused by maternal genital infection in 30–50% of cases and lead to serious complications in the newborn. Clearing infections in the vagina can reduce the rate of pre-term births. Studies explored the use of probiotics, such as Lactobacillus preparations and yoghurts containing live cultures, either orally or vaginally, by women diagnosed with bacterial vaginosis in early pregnancy. A Cochrane review concluded that whilst probiotics reduced risk of genital infection by 81%, there was insufficient data to firmly conclude in the few trials that probiotics can prevent pre-term labour or its complications.181 Another Cochrane review did find that probiotics are particularly useful for the prevention of severe necrotising enterocolitis in pre-term during enteral feeding by the infant.182
Pelvic and back pain in pregnancy
A Cochrane review was undertaken of 8 studies (1305 participants) that examined the effects of adding various pregnancy-specific exercises, physiotherapy, acupuncture and pillows to usual prenatal care.183 Women who were not instructed to do exercise, stretching or have acupuncture and just received usual prenatal care reported more use of analgesics, physical modalities and sacroiliac belts.
Exercise helps back pain
The abovementioned Cochrane review found strengthening exercises, stabilising exercises, sitting pelvic tilt exercises and water gymnastics reduced pain intensity and back pain-related sick leave in pregnant women more than usual prenatal care alone.183
Acupuncture helps pelvic and back pain
The Cochrane reviewers found that acupuncture relieved pelvic pain, particularly relief from evening pain, more than exercises, and in 1 study was more effective than physiotherapy in reducing the intensity of pain. Acupuncture relieved intensity of pain by up to 60% compared to 14% of those receiving usual prenatal care.183
A systematic review of the literature that included 3 RCTs found statistically significant reduction in pain using acupuncture compared with control, particularly the combination of acupuncture and standard treatment with physiotherapy, for women suffering mixed pelvic and back pain in pregnancy.184 No serious adverse events were reported across all trials with only minor adverse events, such as local pain, bruising, sweating and nausea.184
Labour and labour pain
Mind–body factors and labour
Ten percent of women experience fear of labour. Feeling fear without counselling was associated with a negative birth experience.185 Counselling helped women have a more positive experience with childbirth but, of interest, it was associated with a higher risk of having a caesarean section.
More research is required to explore non-drug and surgical interventions for the safe delivery of the newborn as interventions such as caesarean sections carry a high risk to both mothers and newborns and whilst epidurals are effective in reducing pain they come at a high risk, resulting in higher chances of instrumental delivery.186
Music and labour
Music plays an important role in the management of anxiety (see Chapter 4 on anxiety) and for pain relief. A systematic review of the literature identified 51 studies involving 3663 patients experiencing acute or chronic pain (not pregnant) and found music reduced pain by up to 50%, and reduced the need for morphine-like analgesics.187 It would appear calm, gentle, soothing music may play a role in helping reduce pain and anxiety during labour, as gentle music poses little risk or harm to the mother, although research is required to confirm this.
Yoga and labour
Practising regular yoga during pregnancy is associated with improved birth outcomes, improved maternal comfort and reduced labour pain.188–191 Also, yoga practise was associated with higher incidence of vaginal birth rate and less need for caesarean section.
Acupuncture, acupressure, hypnosis, massage, relaxation, aromatherapy and labour
A Cochrane literature review explored trials using non-drug approaches such as acupuncture, mind-body techniques, massage, reflexology, herbal medicines, homoeopathy, hypnosis and music for pain management during labour.192 They identified 14 trials including 1448 pregnant women:
Water births and labour
A Cochrane review of 8 trials including 2939 women found statistically significant reduction in pain and the use of epidural/spinal/paracervical analgesia/anaesthesia amongst women allocated to water immersion during the first stage of labour compared to those not allocated to water immersion.193 Also, women were less likely to require analgesia and there were no adverse outcomes on labour duration, operative delivery or neonatal outcomes, although more research is still warranted.
Pelvic floor exercises and labour
A study of 120 healthy nulliparous women who engaged in a series of weekly pelvic floor training sessions over 12 weeks in the second half of the pregnancy, experienced better childbirth than women in the control group who experienced longer active pushing in the second stage of labour.194
Breech
External cephalic version (ECV) and breech
ECV is often overlooked as a suitable option for breech presentation in favour of caesarean section.197
Moxibustion and breech
Moxibustion is a method used in Chinese medicine that involves the burning of a herb close to the skin. In breech, traditional Chinese medicine (TCM) practitioners apply moxibustion near the little toe. A Cochrane review identified 3 trials of 597 women, but only 1 trial reported relevant outcome measures.198 This study demonstrated that moxibustion reduced the need for ECV or the use of oxytocin before and during labour for women who had vaginal deliveries. Whilst the authors concluded the research to date is not convincing, it would appear a very simple, non-harmful approach to trial if needed.
Labour pain
Perineal massage and labour
A Cochrane review of 3 good quality trials involving 2434 women comparing digital perineal massage with control demonstrated a clear benefit using perineal massage during pregnancy as little as once or twice weekly from 35 weeks gestation.199 Antenatal perineal massage significantly reduced the incidence of perineal trauma requiring suturing (episiotomy) especially in women without previous vaginal birth. In women with a history of previous vaginal birth they reported significant reduction of pain at 3 months post-partum.199 As such, women should be encouraged to undertake perineal massage, which can be done by the woman or her partner.
Perineal pain after labour
Cooling packs
Perineal tears following labour can cause much pain and discomfort for the mother and it is common practice after labour to apply ice or cold packs onto tears or cuts. 200 A review of the literature demonstrates that ice packs provide pain relief up to 72 hours following birth but women preferred gel pads (ease of use) when compared with ice packs or no treatment. There were no differences in level of bruising or oedema in each group.200
Antenatal and postnatal depression
A Cochrane review found too few trials to confidently make any recommendations for other therapies, such as massage therapy or depression-specific acupuncture, for the treatment of antenatal depression.202
A meta-analyses of the literature identified 9 studies (n = 956) that found psychosocial interventions such as peer support or non-directive counselling, cognitive behavioural therapy (CBT), interpersonal psychotherapy, and psychodynamic therapy significantly reduced evidence of depression within the first year after delivery, compared to usual care in women with PND.203 Professional counselling reduced rates of PND by 40%, while support from other mothers reduced the risk by up to 50%. Research consistently supports the value of psychological and psychosocial support in reducing the incidence of PND.204
Infants of mothers with PND are more likely to experience cognitive and psychomotor developmental delays, although the mechanism is not clear.205
Lifestyle and AND/PND
There is clear evidence that lifestyle factors, such as diet, exercise, sunshine, sleep and stress management, play an important role in the management of depression. (See Chapter 12 for more information on depression.)
Psychosocial and psychological support and AND/PND
Antidepressant use in pregnancy should be avoided as much as possible, because of adverse effects on the fetus, and should be weighed against the risk and harm to the mother.206–209 Counselling is not only recommended for treatment of depression but can help reduce risk of developing depression.
Sleep and PND
Two-thirds of clinically significant depression symptoms in pregnancy occur in mothers reporting an infant with a sleep problem. An Australian study of mothers with infants 6–12 months of age found that sleep deprivation was a factor in PND.210 If the infant had a sleep problem, the mother was twice as likely to have PND. The same group showed that by improving the mother’s sleep, this improved the PND.211
In another study, this group is investigated for behavioural intervention for sleep problems on maternal depression.212 They concluded that sleep intervention in infancy resulted in sustained positive effects on maternal depression.
Fish oils and PND
It is well recognised that a diet high in fish and omega-3 supplementation may help with depression. (See Chapter 12 for more information on depression.) A small pilot study found omega-3 supplementation may help women with PND.213 A review of the literature found 3 trials of omega-3 fatty acids versus placebo for perinatal depression show conflicting results.214 It is likely women with lower levels of omega-3 fatty acids during pregnancy are more likely to develop depression than those with higher levels.
Herbal medicine
Safety of herbs in pregnancy
There is little research that supports the safety and use of many herbs in pregnancy, except for a few such as ginger, and one needs to rely on traditional evidence. For instance, the herb liquorice is known to inhibit cortisol metabolism and increase blood pressure, and may increase the risk of pre-term pregnancy.216 Traditionally liquorice was used to induce abortions.
One study looked at the use and safety of echinacea in pregnant women compared with control for the treatment of upper respiratory tract infections.217 There was no increase in congenital malformations in the echinacea group versus the placebo group.
Breastfeeding
An early study on breastfeeding and cognitive function has suggested that a longer duration of breastfeeding benefits cognitive development.222 This was confirmed by a subsequent meta-analysis.223
A recent study, that is the largest randomised trial ever conducted in the area of human lactation, provides significantly strong evidence that prolonged and exclusive breastfeeding improves children’s cognitive development.224
What has been reported to be of further importance is maternal intake of very-long-chain n-3 polyunsaturated fatty acids (PUFAs) during pregnancy and lactation, which may have significant favourable effects for later mental development of children.225 Additional studies have confirmed these results.226, 227
Lactational amenorrhoea — family planning
Lactational amenorrhea method (LAM) is a contraceptive method where the mother uses breastfeeding also for contraception. It has a failure rate of 0.9 to 1.2% and in other studies up to 2.45%, so cannot be relied on solely but together with other methods, such as the use of condoms, it can be a very effective natural method of contraception.228
Conclusion
So, in summary, healthy lifestyle and behavioural changes before, during and after pregnancy can positively impact on the mother’s and child’s wellbeing.
Clinical tips handout for patients — pregnancy
1 Lifestyle advice
Sunshine
2 Physical activity/exercise
3 Mind–body medicine
5 Dietary changes
Refer to the website for Foods Standards Australia New Zealand for more information:
http://www.foodstandards.gov.au/_srcfiles/Listeria.pdf
Nutrition
6 Physical therapies
7 Supplements
Fish oils
Multivitamins and minerals
Vitamins
Do not take vitamin E supplements in early pregnancy as it is linked to heart problems in the baby.
Vitamin B6, B12
Contraindicated: vitamin B6 in high dosage (>50mgs/day) especially with long-term use.
Vitamin D3
Vitamin C
Vitamin E
Minerals
Iron
Magnesium and calcium (best provided together)
Copper
Zinc
Iodine
1 Skouteris H., Wertheim E.H., Rallis S., et al. Use of complementary and alternative medicines by a sample of Australian women during pregnancy. ANZJ Obstet Gynecol. 2008;48:384-390.
2 Hedvig N., Gro C.H. Use of herbal drugs in pregnancy: a survey among 400 Norwegian women. Pharmacoepidemiology and Drug Safety. 2004;13:371-380.
3 Forster D.A., Denning A., Wills G. Herbal medicine use during pregnancy in a group of Australian women. BMC Pregnancy and Childbirth. 2006;6:21.
4 Murtagh J. General Practice.mcgraw–Hill, Australia, 4th Ed. ISBN: 0074717790 EAN: 9780074717790.
5 Lee K.A., Gay C.L. Sleep in late pregnancy predicts length of labour and type of delivery. Ame J Obstet Gynecol. 2004;191:2041-2046.
6 Saisto T., Salmela-Aro K., Nurmi J.E., et al. Psychosocial characteristics of women and their partners fearing vaginal childbirth. BJOGl. 2001;108:492-498.
7 HeatherRowe J., Maggie Kirkman, Annarella Hardiman E., et al. Considering abortion: a 12-month audit of records of women contacting a Pregnancy Advisory Service. MJA. 2009;190(2):69-72.
8 Dennis C.-L., Hodnett E., Reisman Heather M., et al. Effect of peer support on prevention of postnatal depression among high risk women: multisite randomised controlled trial. Published 15 January 2009, doi:10.1136/bmj.a3064 Cite this as: BMJ. 2009;338:a3064.
9 Smith G.C.S., Pell J.P., Dobbie R. Interpregnancy interval and risk of pre-term birth and neonatal death: retrospective cohort study. BMJ. 2003;327:313-316.
10 Duncombe D., Skouteris H., Eleanor H., et al. Vigorous exercise and birth outcomes in a sample of recreational exercisers: A prospective study across pregnancy. ANZ J Obstet Gynaecol. 2006;46:288-292.
11 Kramer M.S., McDonald S.W. Aerobic exercise for women during pregnancy. Cochrane Database of Systematic Reviews. (Issue 3):2006. Art. No.: CD000180. doi: 10.1002/14651858.CD000180.pub2
12 Hansen C., Neller A., Williams G., et al. Maternal exposure to low levels of ambient air pollution and pre-term birth in Brisbane, Australia. BJOG. 2006;113:935-941.
13 McCowan Lesley M.E., Dekker Gustaaf A., Chan Eliza, et al. Spontaneous pre-term birth and small for gestational age infants in women who stop smoking early in pregnancy: prospective cohort study. Published 26 March 2009, doi:10.1136/bmj.b1081. Cite this as: BMJ. 2009;338:b1081.
14 McDonald S.D., Perkins S.L., Jodouin C.A., et al. Folate levels in pregnant women who smoke: an important gene/environment interaction. Am J Obstet Gynecol. 2002 Sep;187(3):620-625. PubMed PMID: 12237638
15 Linnet K.M., Wisborg K., Obel C., et al. Smoking during pregnancy and the risk for hyperkinetic disorder in offspring. Pediatrics. 2005 Aug;116(2):462-467.
16 Elliott E.J., Bower C.. Alcohol and pregnancy: the pivotal role of the obstetrician. Aust NZ J Obstet Gynecol. 2008;48:236-239. Online. Avaialble: www.nhmrc.gov.au/guidelines/_files/draft_australian_alcohol_guidelines.pdf (accessed April 2010)
17 Henderson J., Gray R., Brocklehurst P. Systematic review of effects of low/moderate prenatal alcohol exposure on pregnancy outcome. BJOG. 2007;114:243-252.
18 O’Leary C.M., Nassar N., Kurinczuk J.J., et al. The effect of maternal alcohol consumption on fetal growth and pre-term birth. BJOG. 2009;116:390-400.
19 Mengel M.B., Searight H.R., Cook K. Clinical review preventing alcohol/exposed pregnancies. Amer Board Fam Med. 2006;19:494-505.
20 Summers Brooke L., Rofe Allan M. Peter Coyle Dietary Zinc Supplementation Throughout Pregnancy Protects Against Fetal Dysmorphology and Improves Postnatal Survival After Prenatal Ethanol Exposure in Mice. Alcoholism: Clinical and Experimental Research. Published Online: Jan 12 2009. doi: 10.1111/j.1530–0277.2008.00873.x
21 Thorsdottir I., Torfadottir J.E., Birgisdottir B.E., et al. Weight gain in women of normal weight before pregnancy: complications in pregnancy or delivery and birth outcome. Obstet Gynecol. 2002;99:799-806.
22 Asbee Shelly M., Jenkins Todd R., Butler Jennifer R., et al. Preventing Excessive Weight Gain During Pregnancy Through Dietary and Lifestyle Counseling: A Randomised Controlled Trial. Obstetrics and Gynecology. 2009 February;113(2-1):305-312. doi: 10.1097/AOG.0b013e318195baef
23 Cedergren M.I. Maternal morbid obesity and the risk of adverse pregnancy outcome. Obstet Gynecol. 2004;103:219-224.
24 Vahratian A., et al. Maternal prepregnancy overweight and obesity and the patter of labour progression in term nulliparous women. Obstet Gynecol. 2004;104:943-951.
25 van der Steeg J.W., Steures P., Eijkemans M.J., et al. Obesity affects spontaneous pregnancy chances in subfertile, ovulatory women. Hum Reprod. 2008 Feb;23(2):324-328.
26 Leddy M.A., Power M.L., Schulkin J. The impact of maternal obesity on maternal and fetal health. Rev Obstet Gynacol. 2008;1:170-178.
27 Nohr E.A., Bech B.H., Davies M.J., et al. Prepregnancy Obesity and Fetal Death: A Study Within the Danish National Birth Cohort. Obstet Gynecol. 2005;106:250-259.
28 Vujkovic M., Steegers E.A., Looman C.W., et al. The maternal Mediterranean dietary pattern is associated with a reduced risk of spina bifida in the offspring. British Journal of Obstetrics and Gynecology. 2009;116(3):408-415.
29 Marijana Vujkovic, Ocke Marga C., van der Spek Peter J., et al. Maternal Western Dietary Patterns and the Risk of Developing a Cleft Lip With or Without a Cleft Palate. Obstetrics and Gynecology. August 2007;110:378-384. © 2007 by The American College of Obstetricians and Gynecologists
30 Woods R.K., Thien F.C., Abramson M.J. Dietary marine fatty acids (fish oil) for asthma. Cochrane Database Syst Rev. (4):2000. CD001283
31 Dunstan J.A., Mori T.A., Barden A., et al. Fish oil supplementation in pregnancy modifies neonatal allergen-specific immune responses and clinical outcomes in infants at high risk of atopy: a randomised, controlled trial. J Allergy Clin Immunol. 2003 Dec;112(6):1178-1184.
32 Myers G.J., Davidson P.W., Strain J.J. Nutrient and methyl mercury exposure from consuming fish. J Nutr. 2007;137(12):2805-2808.
33 Foods Standards Australia New Zealand. Online. Available: www.foodstandards.gov.au/foodmatters/mercuryinfish.cfm (accessed January 2009).
34 Stanton R. Complete Book of Food and Nutrition. Sydney: Simon and Schuster; 2007.
35 Shabert J.K. Krause’s Food and Nutrition and Diet Therapy, 11th edn, Philadelphia: Saunders; 2004:182-213. Chapter 7
36 Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG). Online. Available: http://www.ranzcog.edu.au/publications/statements/C-obs25.pdf (accessed February 2009).
37 Williams C., Birch E.E., Emmett P.M., et al. Stereoacuity at age 3.5 y in children born full-term is associated with prenatal and postnatal dietary factors: a report from a population-based cohort study. AJCN. 2001;73(2):316-322.
38 Dunstan J.A., Prescott S.L. Does fish oil supplementation in pregnancy reduce the risk of allergic disease in infants? Curr Opin Allergy Clin Immunol. 2005;5(3):215-221.
39 Auestad N., Scott D.T., Janowsky J.S., et al. Visual, cognitive, and language assessments at 39 months: a follow-up study of children fed formulas containing long-chain polyunsaturated fatty acids to 1 year of age. Pediatrics. 2003;112(3 Pt 1):e177-e183.
40 Helland I.B., Saugstad O.D., Smith L., et al. Similar effects on infants of n-3 and n-6 fatty acids supplementation to pregnant and lactating women. Pediatrics. 2001;108(5):E82.
41 Helland I.B., Smith L., Saarem K., et al. Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children’s IQ at 4 years of age. Pediatrics. 2003;111(1):e39-e44.
42 Dunstan J.A., Roper J., Mitoulas L., et al. The effect of supplementation with fish oil during pregnancy on breast milk immunoglobulin A, soluble CD14, cytokine levels and fatty acid composition. Clin Exp Allergy. 2004;34(8):1237-1242.
43 Olsen S.F., Østerdal M.L., Salvig J.D., et al. Fish oil intake compared with olive oil intake in late pregnancy and asthma in the offspring: 16 y of registry-based follow-up from a randomised controlled trial. ALCN. 2008;88(1):167-175.
44 Olsen S.F., Sørensen J.D., Secher N.J., et al. Randomised controlled trial of effect of fish-oil supplementation on pregnancy duration. Lancet. 1992;339(8800):1003-1007.
45 Martinez M. Tissue levels of polyunsaturated fatty acids during early human development. J Pediatr. 1992;120(4 pt 2):S129-S138.
46 Harris W.S., Connor W.E., Lindsey S. Will dietary omega-3 fatty acids change the composition of human milk? AJCN. 1984;40(4):780-785.
47 Helland I.B., Saarem K., Saugstad O.D., et al. Fatty acid composition in maternal milk and plasma during supplementation with cod liver oil. Eur J Clin Nutr. 1998;52(11):839-845.
48 Bakker E.C., Ghys A.J., Kester A.D., et al. Long-chain polyunsaturated fatty acids at birth and cognitive function at 7 y of age. Eur J Clin Nutr. 2003;57(1):89-95.
49 Ghys A., Bakker E., Hornstra G., et al. Red blood cell and plasma phospholipid arachidonic and docosahexaenoic acid levels at birth and cognitive development at 4 years of age. Early Hum Dev. 2002;69(1–2):83-90.
50 Innis S.M., Gilley J., Werker J. Are human milk long-chain polyunsaturated fatty acids related to visual and neural development in breast-fed term infants? J Pediatr. 2001;139(4):532-538.
51 Smuts C.M., Huang M., Mundy D., et al. A randomised trial of docosahexaenoic acid supplementation during the third trimester of pregnancy. Obstet Gynecol. 2003;101(3):469-479.
52 Malcolm C.A., McCulloch D.L., Montgomery C., et al. Maternal docosahexaenoic acid supplementation during pregnancy and visual evoked potential development in term infants: a double blind, prospective, randomised trial. Arch Dis Child Fetal Neonatal Ed. 2003;88(5):F383-F390.
53 Colombo J., Kannass K.N., Shaddy D.J., et al. Maternal DHA and the development of attention in infancy and toddlerhood. Child Dev. 2004;75(4):1254-1267.
54 Lauritzen L., Jorgensen M.H., Olsen S.F., et al. Maternal fish oil supplementation in lactation: effect on developmental outcome in breast-fed infants. Reprod Nutr De. 2005;45(5):535-547.
55 Jensen C.L., Voigt R.G., Prager T.C., et al. Effects of maternal docosahexaenoic acid intake on visual function and neurodevelopment in breastfed term infants. AJCN. 2005;82(1):125-132.
56 Dunstan J.A., Simmer K., Dixon G., et al. Cognitive assessment at 2(1/2) years after fish oil supplementation in pregnancy: a randomised controlled trial. Arch Dis Child Fetal Neonatal Ed. 2008;93(1):F45-F50.
57 Helland I.B., Smith L., Saarem K., et al. Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children’s IQ at 4 years of age. Pediatrics. 111(1), 2003.
58 Innis S.M., Friessen R.W. Essential n-3 fatty acids inpregnant women and early visual acuity maturation in term infants. Am J Clin Nutr. 2008;87(3):548-557.
59 Eilander A., Hundscheid D.C., Osendarp S.J., et al. Effects of n-3 long chain polyunsaturated fatty acid supplementation on visual and cognitive development throughout childhood: a review of human studies. Prostaglandins Leukot Essent Fatty Acids. 2007;76(4):189-203.
60 Decsi T., Koletzko B. N-3 fatty acids and pregnancy outcomes. Curr Opin Clin Nutr Metab Care. 2005;8(2):161-166.
61 Helland I.B., Smith L., Blomén B., et al. Effect of supplementing pregnant and lactating mothers with n-3 very-long-chain fatty acids on children’s IQ and body mass index at 7 years of age. Pediatrics. 2008;122(2):e472-e479.
62 Haider B.A., Bhutta Z.A. Multiple micronutrient supplementation for women during pregnancy. Cochrane Database of Systematic Reviews. (Issue 4):2006. Art. No.: CD004905. doi: 10.1002/14651858.CD004905.pub2
63 Goh Y.I., Bollano E., Einarson T.R., et al. Prenatal multivitamin supplementation and rates of pediatric cancers: a meta–analysis. Clin Pharmacol Ther. 2007;81:685-691.
64 van den Broek N., Kulier R., Gülmezoglu A.M., et al. Vitamin A supplementation during pregnancy. Cochrane Database of Systematic Reviews. (Issue 4):2002. Art. No.: CD001996. doi: 10.1002/14651858.CD001996
65 Rumbold A., Crowther C.A. Vitamin C supplementation in pregnancy. Cochrane Database of Systematic Reviews. (Issue 1):2005. Art. No.: CD004072. doi: 10.1002/14651858.CD004072.pub2
66 Hollis B.W., Wagner C.L. Editorial. Vitamin D deficiency during pregnancy: an ongoing epidemic. AJCN. 2006;84:273.
67 Van der Meer I.M., Karamali N.S., Boeke J.P., et al. High prevalence of vitamin D deficiency in pregnant non-Western women in the Hague, Netherlands. Am J Clin Nutr. 2006;84:350-353.
68 Munns C., Zacharin M.R., et al. Prevention and treatment of infant and childhood vitamin D deficiency in Australia and New Zealand: a consensus statement. MJA. 2006;185:268-272.
69 Weisber P., Kelley S.S., Ruowei Li, et al. Nutritional rickets among children in the United States:review of cases reported between 1986–2003. Am J Clin Nutr. 2004;80(suppl):1697S-1705S.
70 Pettifor J.M. Nutritional rickets: deficiency of vitamin D, calcium, or both? Am J Clin Nutr. 2004;80(suppl):1725S-1729S.
71 Nozza J.M., Rodda C.P. Vitamin D deficiency in mothers of infants with rickets. MJA. 2001;175:253-255.
72 Mahomed K., Gulmezoglu A.M. Vitamin D supplementation in pregnancy. Cochrane Database of Systematic Reviews. (Issue 1):1999. Art. No.: CD000228. doi: 10.1002/14651858.CD000228
73 Wen S.W., Chen X.K., Rodger M., et al. Folic acid supplementation in early second trimester and the risk of preeclampsia. Am J Obstet Gynecol. 2008;198(1):45.e1-45.e7.
74 Mills G.L., Johansson A., Nordmark A., et al. Plasma foalte levels and risk of spontaneous abortion. JAMA. 2002;288:1867-1873.
75 Hernández-Díaz S., Werler M.M., Walker A.M., et al. Folic acid antagonists during pregnancy and the risk of birth defects. NEJM. 2000;343:1608-1614.
76 Krapels I.P., van Rooij I.A., Ocké M.C., et al. Maternal dietary B vitamin intake, other than folate, and the association with orofacial cleft in the offspring. Eur J Nutr. 2004;43(1):7-14. Epub 2004 Jan 6
77 Krapels I.P., van Rooij I.A., Ocké M.C., et al. Maternal nutritional status and the risk for orofacial cleft offspring in humans. Nutr. 2004;134(11):3106-3113.
78 Lumley J., Watson L., Watson M., et al. Periconceptional supplementation with folate and/or multivitamins for preventing neural tube defects. Cochrane Database of Systematic Reviews. (Issue 3):2001. Art. No.: CD001056. doi: 10.1002/14651858.CD001056
79 Wen S.W., Zhou J., Yang Q., et al. Maternal exposure to folic acid antagonists and placenta-mediated adverse pregnancy outcomes. CMAJ. 2009;179:1263-1268.
80 Wen S.W., Walker M. Risk of fetal exposure to folic acid antagonists. J Obstet Gynaecol Can. 2004;26:475-480.
81 Lagrange A.H. Folic acid supplementation for women with epilepsy who might become pregnant nature clinical practice neurology. Nature Clinical Practice Neurology. 2009;5(1):16-17.
82 Vajda F.J., O’Brien T.J., Hitchcock A., et al. Critical relationship between sodium valproate dose and human teratogenicity: results of the Australian register of anti-epileptic drugs in pregnancy. J Clin Neurosci. 2004 Nov;11(8):854-883.
83 Whitehall J., Smith J. Valproate and babies. Aust NZ J Psychiatry. 2008;42:837.
84 Chavarro J.E., Rich-Edwards J.W., et al. Iron intake and risk of ovulatory infertility. Obstet Gynecol. 2006;108:1145-1152.
85 Lozoff B., De Andraca I., Castillo M., et al. Behavioural and developmental effects of preventing iron-deficiency anemia in healthy full-term infants. Pediatrics. 2003;112(4):846-854.
86 Eden A.N. Iron deficiency and impaired cognition in toddlers: an underestimated and undertreated problem. Paediatr Drugs. 2005;7(6):347-352.
87 Peña-Rosas J.P., Viteri F.E. Effects of routine oral iron supplementation with or without folic acid for women during pregnancy. Cochrane Database of Systematic Reviews. (Issue 3):2006. Art. No.: CD004736. doi: 10.1002/14651858.CD004736.pub2
88 Favier M., Hininger-Favier I. Zinc and pregnancy. Gynecol Obstet Fertil. 2005;33(4):253-258.
89 Merialdi M., et al. Randomised controlled trial of prenatal zinc supplementation and fetal bone growth. AJCN. 2004;79:826-830.
90 Fawzi W.W., Villamor E., Msamanga G.I., et al. Improves infant mortality, birth weight and duration of pregnancy in HIV mums:Trial of zinc supplements in relation to pregnancy outcomes, hematologic indicators, and T cell counts among HIV-1-infected women in Tanzania. Am J Clin Nutr. 2005;81:161-167.
91 Mahomed K., Bhutta Z., Middleton P. Zinc supplementation for improving pregnancy and infant outcome. Cochrane Database of Systematic Reviews. (Issue 2):2007. Art. No.: CD000230. doi: 10.1002/14651858.CD000230.pub3
92 Osendarp S.J., van Raaij J.M., Darmstadt G.L., et al. Zinc supplementation during pregnancy and effects on growth and morbidity in low birth weight infants: a randomised placebo controlled trial. Lancet. 2001;357:1080-1085.
93 Travers C.A., et al. Iodine status in pregnant women and their newborns: are our babies at risk of iodine deficiency? MJA. 2006;184:617-620.
94 Gunton J.E., Hams G., Fiegert M., et al. Iodine deficiency in ambulatory participants at a Sydney teaching hospital: is Australia truly iodine replete. MJA. 1999;171(9):467-470.
95 Glinoer D. Feto-maternal repercussions of iodine deficiency in pregnancy. Ann Endocrinol. 2003;64(1):37-44.
96 Xue-Yi C., Jiang X.M., Dou Z.H., et al. Timing of vulnerability of the brain to iodine deficiency in endemic cretinism. NEJM. 1994;331(26):1739-1744.
97 Kozhimannil K.B., Pereira M.A., Harlow B.L. Association between diabetes and perinatal depression among low-income mothers. JAMA. 2009 Feb 25;301(8):842-847.
98 Zhang C., Solomon C.G., Manson J.E., et al. A prospective study of pregravid physical activity and sedentary behaviours in relation to the risk for gestational diabetes mellitus. Arch Intern Med. 2006 Mar 13;166(5):543-548.
99 Moses Robert G, Barker Megan, Winter Meagan, et al. Gestational diabetes; can a low glycemic index diet reduce the need for insulin? A randomised trial. Diabetes Care Publish Ahead of Print published online ahead of print March 11, 2009. doi: 10.2337/dc09–0007.
100 Tieu J., Crowther C.A., Middleton P. Dietary advice in pregnancy for preventing gestational diabetes mellitus. Cochrane Database of Systematic Reviews. (Issue 2):2008. Art. No.: CD006674. doi: 10.1002/14651858.CD006674.pub2
101 Ray J.G., Vermeulen M.J., Shapiro J.L., et al. Maternal and neonatal outcomes in pregestational and gestational diabetes mellitus, and the influence of maternal obesity and weight gain: the DEPOSIT study. Diabetes Endocrine Pregnancy Outcome Study in Toronto. QJM. 2001;94:347-356.
102 Hamano T. Women with a history of preeclampsia should be monitored for the onset and progression of chronic kidney disease. J Nutr. 2007;137:2805-2808.
103 Marcoux S., Bérubé S., Brisson C., et al. Job strain and pregnancy-induced hypertension. Epidemiology. 1999;10:376-382.
104 Walker S.P., Permezel M., Brennecke S.P., et al. Blood pressure in late pregnancy and work outside the home. Obstetrics and Gynecology. 2001;97:361-365.
105 Qui C., Coughlin K.B., Frederick I.O., et al. Dietary fibre intake in early pregnancy and risk of subsequent preeclampsia. Am JHypertension. 2008;21:903-909.
106. Duley L., Henderson-Smart D., Meher S. Altered dietary salt for preventing pre-eclampsia, and its complications. Cochrane Database of Systematic Reviews. (Issue 4):2005. Art. No.: CD005548. doi: 10.1002/14651858.CD005548
107 Rumbold A., Duley L., Crowther C.A., et al. Antioxidants for preventing pre-eclampsia. Cochrane Database of Systematic Reviews. (Issue 1):2008. Art. No.: CD004227. doi: 10.1002/14651858.CD004227.pub3
108 Rumbold A., Middleton P., Crowther C.A. Vitamin supplementation for preventing miscarriage. (Issue 2):2005. Cochrane Database of Systematic ReviewsArt. No.: CD004073. doi: 10.1002/14651858.CD004073.pub2
109 Rumbold A., Crowther C.A. Vitamin E supplementation in pregnancy. Cochrane Database of Systematic Reviews. (Issue 2):2005. Art. No.: CD004069. doi: 10.1002/14651858.CD004069.pub2
110 Chappell Lucy C., Seed Paul T., Briley Annette L., et al. Effect of Antioxidants on the Occurrence of Pre-Eclampsia in Women at Increased Risk: A Randomised Trial. Obstetrical Gynecological Survey. 2000;55:129-130.
111 Chappell Lucy C., Seed Paul T., et al. Vitamin C and E supplementation in women at risk of preeclampsia is associated with changes in indices of oxidative stress and placental function. Am J Obstet Gynecol. 2002;187:777-784.
112 Beazley D., Ahokas R., Livingston J., et al. Vitamin C and E supplementation in women at high risk for preeclampsia: A double-blind, placebo-controlled trial. American Journal of Obstetrics and Gynecology. 2002;192:520-521.
113 Poston L., Briley A.L., Seed P.T., et al. Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial. Lancet. 2006;367:1145-1154.
114 Smedts H.P.M., de Vries J.H., Rakhshandehroo M., et al. High maternal vitamin E intake by diet or supplements is associated with congenital heart defects in the offspring. British Journal of Obstetrics and Gynaecology. 2009;16(3):416-423.
115 Villar J., Merialdi M., Gulmezoglu A.M. Nutritional interventions during pregnancy for the prevention or treatment of maternal morbidity and pre-term delivery: An overview of randomised controlled trials. J Nutr. 2003;133:1606S-1625S.
116 Kumar A., Shukla D.K., et al. Calcium supplementation for the prevention of pre-eclampsia. Int J Gynaecol Obstet. 2008;104(1):32-36.
117 Villar J., Abdel-Aleem H., Merialdi M., et al. World Health Organization randomised trial of calcium supplementation among low calcium intake pregnant women. Am J Obstet Gynecol. 2006;194:639-649.
118 Hofmeyr G.J., Atallah A.N., Duley L. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database of Systematic Reviews. (Issue 3):2006. Art. No.: CD001059. doi: 10.1002/14651858.CD001059.pub2
119 Makrides M., Crowther C.A. Magnesium supplementation in pregnancy. Cochrane Database of Systematic Reviews. (Issue 4):2001. Art. No.: CD000937. doi: 10.1002/14651858.CD000937
120 Altman D., Carroli G., Duley L., et al. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. Lancet. 2002;359:1877-1890.
121 Meher S., Duley L. Garlic for preventing pre-eclampsia and its complications. Cochrane Database of Systematic Reviews. (Issue 3):2006. Art. No.: CD006065. doi: 10.1002/14651858.CD006065
122 Jewell D., Young G. Interventions for nausea and vomiting in early pregnancy. Cochrane Database of Systematic Reviews. (Issue 4):2003. Art. No.: CD000145. doi: 10.1002/14651858.CD000145
123 Renwick A.G. Toxicology of micronutrients: Adverse effects and uncertainty. J Nutr. 2006;136:493S-501S.
124 Australian Adverse Drug Reactions Bulletin 2008 August;27;(4).
125 Thaver D., Saeed M.A., Bhutta Z.A. Pyridoxine (vitamin B6) supplementation in pregnancy. Cochrane Database of Systematic Reviews. (Issue 2):2006. Art. No.: CD000179. doi: 10.1002/14651858.CD000179.pub2
126 Thaver D., Saeed M.A., Bhutta Z.A. Pyridoxine (vitamin B6) supplementation in pregnancy. Cochrane Database of Systematic Reviews. (Issue 2):2006. Art. No.: CD000179. doi: 10.1002/14651858.CD000179.pub2
127 Jewell D., Young G. Interventions for nausea and vomiting in early pregnancy. The Cochrane Database of Systematic Reviews. (Issue 4):2003. Art. No.: CD000145. doi: 10.1002/14651858.CD000145
128 Barrelli F., Capasso R., et al. Effectiveness and safety of ginger in the treatment of pregnancy-induced nausea and vomiting. Obstet Gynecol. 2005;105(4):849-856.
129 Lee A., Done M.L. Stimulation of the wrist acupuncture point P6 for preventing postoperative nausea and vomiting. Cochrane Database of Systematic Reviews. (Issue 3):2004. Art. No.: CD003281. doi: 10.1002/14651858.CD003281.pub2
130 Pack A.R., Thomson M.E. Effects of topical and systemic folic acid supplementation on gingivitis in pregnancy. J Clin Periodontol. 1980;7:402-414.
131 Dahle L.O., Berg G., Hammar M., et al. The effect of oral magnesium substitution on pregnancy-induced leg cramps. Am J Obstet Gynecol. 1995;173:175-180.
132 Young G.L., Jewell D. Interventions for leg cramps in pregnancy. Cochrane Database Syst Rev. (1):2002. CD000121
133 Hammar M., Larsson L., Tegler L. Calcium treatment of leg cramps in pregnancy. Effect on clinical symptoms and total serum and ionized serum calcium concentrations. Acta Obstet Gynecol Scand. 1981;60:345-347.
134 Dengfeng W., Taixiang W., Lina Hu, et al. Chinese herbal medicines in the treatment of ectopic pregnancy. Cochrane Database of Systematic Reviews. (Issue 4):2007. Art. No.: CD006224. doi:10.1002/14651858.CD006224.pub2
135 Maconochie N., Doyle P., Prior S., et al. Risk factors for first trimester miscarriage–results from a UK-population-based case-control study. BJOG. 2007;114(2):170-186.
136 Weng X., Odouli R., Li D.K. Maternal caffeine consumption during pregnancy and the risk of miscarriage: a prospective cohort study. Am J Obstet Gynecol. 2008;198(3):279.e1-279.e8.
137 Rumbold A., Middleton P., Crowther C.A. Vitamin supplementation for preventing miscarriage. Cochrane Database of Systematic Reviews. (Issue 2):2005. Art. No.: CD004073. doi: 10.1002/14651858.CD004073.pub2
138 de la Calle N., Usandizaga R., Sancha M., et al. Homocysteine, folic acid and B-group vitamins in obstetrics and gynaecology. Eur J Obstet Gynecol Reprod Biol. 2003;107(2):125-134.
139 Nelen W.L., Blom H.J., Thomas C.M., et al. Methylenetetrahydrofolate reductase polymorphism affects the change in homocysteine and folate concentrations resulting from low dose folic acid supplementation in women with unexplained recurrent miscarriages. J Nutr. 1998;128(8):1336-1341.
140 Rostami K. Coeliac disease and reproductive disorders: a neglected association. Eur J Obstet Gynecol Reprod Biol. 2001;96(2):146-149.
141 Hetzel B.S. Story of iodine deficiency: an international challenge in nutrition. New York: Oxford University Press; 1989.
142 George L., Mills J.L., Johansson A.L., et al. Plasma folate levels and risk of spontaneous abortion. JAMA. 2002;288:1867-1873.
143 Slama R., Bouyer J., Windham G., et al. Influence of paternal age on the risk of spontaneous abortion. Am J Epidemiol. 2005;161:816-823.
144 Verkleij-Hagoort A.C., de Vries J.H., et al. Dietary intake of B-vitamins in mothers born a child with a congenital heart defect. Eur J Nutr. 2006;45(8):478-486.
145 Smedts H.P., Rakhshandehroo M., Verkleij-Hagoort A.C., et al. Maternal intake of fat, riboflavin and nicotinamide and the risk of having offspring with congenital heart defects. Eur J Nutr. 2008;47(7):357-365.
146 Hobel C., Culhune J. Role of psychosocial and nutritional stress on poor pregnancy outcome. J Nutr. 133, 2003. 1790S–1717S
147 Li D., Liu L., Odouli R. Presence of depressive symptoms during early pregnancy and the risk of pre-term delivery: a prospective cohort study. Hum Reprod. 2009 Jan;24(1):146-153. Epub 2008 Oct 23. PubMed PMID: 18948314
148 DayanCreveuil J., C Herlicoviez M., et al. Role of Anxiety and Depression in the Onset of Spontaneous Pre-term Labour. Am J Epidemiol. 2002;155(4):293-301.
149 Narendran S., Nagarathna R., Narendran V., et al. Swami Vivekananda Yoga Anusandhana Samsthana (sVYASA), Vivekananda Yoga. Research Foundation, Bangalore, India. ‘Efficacy of yoga on pregnancy outcome.J Altern Complement Med. 2005;11(2):237-244.
150 Evenson K.R., Siega-Riz A.M., Savitz D.A., et al. Vigorous Leisure Activity and Pregnancy Outcome. Epidemiology. 2002;13:653-659.
151 Polyzos Nikolaos P., Polyzos Ilias P., Davide Mauri, et al. Effect of periodontal disease treatment during pregnancy on pre-term birth incidence: a metaanalysis of randomised trials. American Journal of Obstetrics and Gynecology. 2009 March:225-232.
152 Marakoglu I., Gursoy U.K., Marakoglu K., et al. Periodontitis as a risk factor for pre-term low birth weight. Yonsei Med J. 2008;49(2):200-203.
153 Pitiphat J., Joshipura K.J., Gillman M.W., et al. Maternal periodontitis and adverse pregnancy outcomes. Community Dent Oral Epidemiol. 2008;36:3-11.
154 Mercer B.M., Merlino A.A., Milluzzi C.J., et al. Small fetal size before 20 weeks’ gestation: associations with maternal tobacco use, early pre-term birth, and low birth weight. Am J Obstet Gynecol. 2008;198(6):673.e1-673.e7.
155 Suzuki K., Tanaka T., Kondo N., et al. Is maternal smoking during early pregnancy a risk factor for all low birth weight infants? J Epidemiol. 2008;18:89-96.
156 Wills R., Coory M.D. Effect of smoking among Indigenous and non-Indigenous mothers on pre-term birth and full-term low birth weight. MJA. 2008;189(9):490-494.
157 Jaddoe V.W.V., Troe E., Hofman A., et al. Active and passive smoking during pregnancy and the risks of low birth weight and pre-term birth: the generation R study. Paed Perinat Epidem. 2008;20:162-171.
158 Leonardi-Bee J., Smyth A., Britton J., et al. Environmental tobacco smoke and fetal health: systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed. 2008;93(5):F351-F361.
159 Kyrklund-Blomberg Nina B. Cnattingius Sven. Pre-term birth and maternal smoking: Risks related to gestational age and onset of delivery. Am J Obstet Gynecol. 1998;179(4):1051-1055.
160 Olsen S.F., Secher N.J. Low consumption of seafood in early pregnancy as a risk factor for pre-term delivery: prospective cohort study. BMJ. 2002;324:447-450.
161 Khoury J., Henriksen T., Christophersen B., et al. Effect of a cholesterol-lowering diet on maternal, cord, and neonatal lipids, and pregnancy outcome: a randomised clinical trial. Am J Obstet Gynecol. 2005;193:1292-1301.
162 Cook Derek G., Peacock Janet L., Colin Feyerabend, et al. Relation of caffeine intake and blood caffeine concentrations during pregnancy to fetal growth: prospective population based study. BMJ. 1996;313:1358-1362.
163 Hammer Bech Bodil, Obel Carsten, et al. Effect of reducing caffeine intake on birth weight and length of gestation: randomised controlled trial. BMJ. 2007;334:409.
164 Clausson B., Granath F., Ekbom A., et al. Effect of caffeine exposure during pregnancy on birth weight and gestational age. Am J Epidemiol. 2002;155:429-436.
165 Bracken M.B., Triche E.W., Belanger K., et al. Association of maternal caffeine consumption with decrements in fetal growth. Am J Epidemiol. 2002;155:429-436.
166 CARE Study Group. Maternal caffeine intake during pregnancy and risk of fetal growth restriction: a large prospective observational study. BMJ. 2008;337:a2332.
167 Wendler C.C., Busovsky-McNeal B., Ghatpande S., et al. Embryonic caffeine exposure induces adverse effects in adulthood. FASEB J. 2008. as doi:10.1096/fj.08–124941
168 Bech B.H., Nohr E.A., Vaeth M., et al. Coffee and fetal death: a cohort study with prospective data. Am J Epidmiol. 2005;162:983-990.
169 McPhee, A. JAMA 2009;301:175–182.
170 Makrides M., Crowther C.A. Magnesium supplementation in pregnancy. Cochrane Database of Systematic Reviews. (Issue 4):2001. Art. No.: CD000937. doi: 10.1002/14651858.CD000937
171 Doyle L.W., Crowther C.A., Middleton P., et al. Magnesium sulphate for women at risk of pre-term birth for neuroprotection of the fetus. Cochrane Database of Systematic Reviews. (Issue 3):2007. Art. No.: CD004661. doi: 10.1002/14651858.CD004661.pub2
172 Nilsen R.M., Vollset S.E., Rasmussen S.A., et al. Folic acid and Multivitamin Supplement Use and Risk of Placental Abruption: A Population-based Registry Study. Am J Epidemiol. 2008. Epub ahead of print
173 Elizabeth K.E., Krishnan V., Zachariah P. Auxologic, biochemical and clinical (ABC) profile of low birth weight babies – a two-year prospective study. Trop Med. 2007;53(6):374-382.
174 Elizabeth K.E., Krishnan V., Vijayakumar T. Umbilical cord blood nutrients in low birth weight babies in relation to birth weight and gestational age. Indian J Med Res. 2008;128(2):128-133.
175 Newman R.B., Goldenberg R.L., Moawad A.H., et al. Occupational fatigue and pre-term premature rupture of membranes. National Institute of Child Health and Human Development Maternal-Fetal Medicine, Units Network. Am J Obstet Gynecol. 2001 Feb;184(3):438-446.
176 Siega-Riz A.M., Herrmann T.S., Savitz D.A., et al. Frequency of eating during pregnancy and its effect on pre-term delivery. Am J Epidemiol. 2001;153:647-652.
177 Siega-Riz A.M., Promislow J.H., Savitz D.A., et al. Vitamin C and the risk of pre-term delivery. Am J Obstet Gynecol. 2003;189(2):519-525.
178 Casanueva E., Ripoll C., Tolentoin M., et al. Vitamin C supplementation to prevent premature rupture of the chorioamnionic membranes: a randomised trial. ACJN. 2005;81:859-864.
179 Woods J.R.Jr., Plessinger M.A., Miller R.K. Vitamins C and E: missing links in preventing pre-term premature rupture of membranes? Am J Obstet Gynecol. 2001 Jul;185(1):5-10.
180 Olsen S.F., Secher N.J., Tabor A., et al. Randomised clinical trials of fish oil supplementation in high risk pregnancies. Fish Oil Trials In Pregnancy (FOTIP) Team. BJOG. 2000;107:382-395.
181 Othman M., Neilson J.P., Alfirevic Z. Probiotics for preventing pre-term labour. Cochrane Database of Systematic Reviews. (Issue 1):2007. Art. No.: CD005941. doi: 10.1002/14651858.CD005941.pub2
182 AlFaleh K.M., Bassler D. Probiotics for prevention of necrotizing enterocolitis in pre-term infants. Cochrane Database of Systematic Reviews. (Issue 1):2008. Art. No.: CD005496. doi: 10.1002/14651858.CD005496.pub2
183 Pennick V., Young G. Interventions for preventing and treating pelvic and back pain in pregnancy. Cochrane Database of Systematic Reviews. (Issue 2):2007. Art. No.: CD001139. doi: 10.1002/14651858.CD001139.pub2
184 Carolyn E., Manheimer E., Pirotta M., White A. Acupuncture for pelvic and back pain in pregnancy: a systematic review. American Journal of Obstetrics and Gynecology. 2008;March:254-259.
185 Waldenström U., Hildingsson I., Ryding E.L. Antenatal fear of childbirth and its association with subsequent caesarean section and experience of childbirth. BJOG. 2006;113:638-646.
186 Anim-Somuah M., Smyth R., Howell C. Epidural versus non-epidural or no analgesia in labour. Cochrane Database of Systematic Reviews. (Issue 4):2005. Art. No.: CD000331. doi: 10.1002/14651858.CD000331.pub2
187 Cepeda M.S., Carr D.B., Lau J., et al. Music for pain relief. Cochrane Database of Systematic Reviews. (Issue 2):2006. Art. No.: CD004843. doi:10.1002/14651858.CD004843.pub2
188 Chuntharapat S., Petpichetchian W., Hatthakit U. Yoga during pregnancy: effects on maternal comfort, labour pain and birth outcomes. Complement Ther Clin Pract. 2008;14:105-115.
189 Narendran S., Nagarathna R., Narendran V., et al. Efficacy of yoga on pregnancy outcome. J Altern Complement Med. 2005;11:237-244.
190 Chuntharapat S., Petpichetchian W., Hatthakit U. Yoga during pregnancy: effects on maternal comfort, labour pain and birth outcomes. Complement Ther Clin Pract. 2008;14:105-115.
191 Narendran S., Nagarathna R., Narendran V., et al. Efficacy of yoga on pregnancy outcome. J Altern Complement Med. 2005;11:237-244.
192 Smith C.A., Collins C.T., Cyna A.M., et al. Complementary and alternative therapies for pain management in labour. Cochrane Database of Systematic Reviews. (Issue 4):2006. Art. No.: CD003521. doi: 10.1002/14651858.CD003521.pub2
193 Cluett E.R., Nikodem V.C., McCandlish R.E., et al. Immersion in water in pregnancy, labour and birth. Cochrane Database of Systematic Reviews. (Issue 2):2002. Art. No.: CD000111. doi: 10.1002/14651858.CD000111.pub2
194 Salvesen K.A., Mørkved S. Randomised controlled trial of pelvic floor muscle training during pregnancy. BMJ. 2004;329:378-380.
195 Smith C.A. Homoeopathy for induction of labour. Cochrane Database of Systematic Reviews. (Issue 4):2003. Art. No.: CD003399. doi: 10.1002/14651858.CD003399
196 Dahlen H.G., Homer C.S., Cooke M., et al. Perineal outcomes and maternal comfort related to the application of perineal warm packs in the second stage of labour: a randomised controlled trial. Birth. 2007;34(4):282-290.
197 Raynes-Greenow C.H., Roberts C.L., Barratt A., et al. Pregnant women’s preferences and knowledge of term breech management, in an Australian setting. Midwifery. 2004;20:181-187.
198 Coyle M.E., Smith C.A., Peat B. Cephalic version by moxibustion for breech presentation. Cochrane Database of Systematic Reviews. (Issue 2):2005. Art. No.: CD003928. doi: 10.1002/14651858.CD003928.pub2
199 Beckmann M.M., Garrett A.J. Antenatal perineal massage for reducing perineal trauma. Cochrane Database of Systematic Reviews. (Issue 1):2006. Art. No.: CD005123. doi: 10.1002/14651858.CD005123.pub2
200 East C.E., Begg L., Henshall N.E., et al. Local cooling for relieving pain from perineal trauma sustained during childbirth. Cochrane Database of Systematic Reviews. (Issue 4):2007. Art. No.: CD006304. doi: 10.1002/14651858.CD006304.pub2
201 Hay-Smith J. Therapeutic ultrasound for post-partum perineal pain and dyspareunia. Cochrane Database of Systematic Reviews. (Issue 3):1998. Art. No.: CD000495. doi: 10.1002/14651858.CD000495
202 Dennis C.L., Allen K. Interventions (other than pharmacological, psychosocial or psychological) for treating antenatal depression. Cochrane Database of Systematic Reviews. (Issue 4):2008. Art. No.: CD006795. doi: 10.1002/14651858.CD006795.pub2
203 Dennis C.L. Review: Psychosocial and psychological interventions reduce post-partum depressive symptoms. Evidence-Based Mental Health. 2008;11:79.
204 Morrell C.J., Slade P., Warner R., et al. Clinical effectiveness of health visitor training in psychologically informed approaches for depression in postnatal women: pragmatic cluster randomised trial in primary care. BMJ. 2009;338:a3045.
205 Cornish A.M., McMahon C.A., Ungerer J.A., et al. Postnatal depression and infant cognitive and motor development in the second postnatal year: The impact of depression chronicity and infant gender. Infant Behav Dev. 2005;28:407-417.
206 Cowley D. Antidepressants in Pregnancy: The Ongoing Story. Journal Watch Psychiatry December 29, 2006. http://psychiatry.jwatch.org/cgi/content/full/2006/1229/4 (accessed February 2009).
207 ACOG Committee on Obstetric Practice. ACOG Committee Opinion No. 354: Treatment with selective serotonin reuptake inhibitors during pregnancy. Obstet Gynecol. 2006;108:1601-1603.
208 Levinson-Castiel R., Merlob P., Linder N., et al. Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants. Arch Pediatr Adolesc Med. 2006;160:173-176.
209 Chun-Fai-Chan B., Koren G., Fayez I., et al. Pregnancy outcome of women exposed to bupropion during pregnancy: a prospective comparative study. Am J Obstet Gynecol. 2005;192:932-936.
210 Hiscock H., Wake M. Infant sleep problems and postnatal depression: a community-based study. Pediatrics. 2001;107(6):1317-1322.
211 Hiscock H., Wake M. Randomised controlled trial of behavioural infant sleep intervention to improve infant sleep and maternal mood. BMJ. 2002;324(7345):1062-1065.
212 Hiscock H., Bayer J.K., Hampton A., et al. Long-term mother and child mental health effects of a population-based infant sleep intervention: cluster-randomised, controlled trial. Pediatrics. 2008;122(3):e621-e627.
213 Freeman M.P., et al. Randomised dose-ranging pilot trial of omega-3 fatty acids for post-partum depression. Acta Psychiatr Scand. 2006;113(1):31-35.
214 M. Freeman. Complementary and alternative medicine for perinatal depression. Journal of Affective Disorders 112(1):1–10.
215 Allen L. Multiple micronutrients in pregnancy and lactation: an overview. AJCN. 2005;81:1206s-1212s.
216 Strandberg T.E., Anderson S., Järvenpää A.L., McKeigue P.M. Premature birth and liquorice consumption during pregnancy. American Journal Epidemiology. 2002;156(9):803-805.
217 Gallo M., et al. Pregnancy outcome following gestational exposure to echinacea: a prospective controlled study. Arch Intern Med. 2000;160:3141-3143.
218 Medicines Control Agency Report. Online. Available: http://www.mhra.gov.uk/index.htm (accessed February 2009).
219 Järvenpää A.L., Vanhanen H., McKeigue P.M. Birth Outcome in Relation to Licorice Consumption during Pregnancy. Am J Epidemiol. 2001;153:1085-1088.
220 Strandberg T.E., Andersson S., Järvenpää A.L., et al. Pre-term Birth and Licorice Consumption during Pregnancy. Am J Epidemiol. 2002;156:803-805.
221 Hughes J., Sellick S., King R., et al. Pre-termbirth and licorice consumption during pregnancy. Am J Epidemiol. 2003;158:190-194.
222 Angelsen N.K., Vik T., Jacobsen G., et al. Breast feeding and cognitive development at age 1 and 5 years. Arch Dis Child. 2001;85(3):183-188.
223 Anderson J.W., Johnstone B.M., Remley D.T. Breast-feeding and cognitive development: a meta-analysis. AJCN. 1999;70(4):525-535.
224 Kramer M.S., Aboud F., Mironova E., et al. Breastfeeding and child cognitive development: new evidence from a large randomised trial. Arch Gen Psychiatry. 2008;65(5):578-584.
225 Helland I.B., Smith L., Saarem K., et al. Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children’s IQ at 4 years of age. Pediatrics. 2003;111(1):e39-e44.
226 Gustafsson P.A., Duchen K., Birberg U., et al. Breastfeeding, very long polyunsaturated fatty acids (PUFA) and IQ at 6 1/2 years of age. Acta Paediatr. 2004;93(10):1280-1287.
227 Lauritzen L., Hoppe C., Straarup E.M., et al. Maternal fish oil supplementation in lactation and growth during the first 2.5 years of life. Pediatr Res. 2005;58(2):235-242.
228 Van der Wijden C., Brown J., Kleijnen J. Lactational amenorrhea for family planning. Cochrane Database of Systematic Reviews. (Issue 4):2003. Art. No.: CD001329. doi: 10.1002/14651858.CD001329. Online. Available: www.cochrane.org/reviews/en/ab001329.html (accessed January 2009)